Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook-square
  • x
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > About Us > Legislation > Notifications

Notifications

S.R.O 2118(I)/2026 Fee for Alternative Medicines and Health Products (16.11.2026)

Ijaz Mustafa Notifications, SROs November 17, 2026November 17, 2026
Fee for Alternative Medicines and Health Products (16.11.2026)Download

S.R.O.2117(I)/2026 (Alternative Medicines and Health Products Rules, 2026 (16.11.2026))

Ijaz Mustafa Notifications, SROs November 17, 2026November 17, 2026
Alternative Medicines and Health Products Rules, 2026 (16.11.2026)Download

Mandatory Compliance,Data Accuracy,System Verification for 2D barcoding  and Serialization Requirments.

Ijaz Mustafa Notifications November 16, 2026November 16, 2026
625dc922-3796-47f0-8c97-fca2a0e7f3c2Download

Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)

Ijaz Mustafa Notifications November 11, 2026November 11, 2026
Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)Download

Clarification Regarding 1688(I)/2026 dated 6,Oct 2026

Ijaz Mustafa General, Notifications November 5, 2026November 5, 2026
11042026060402594Download

Directive Regarding Mandatory Printing of Disclaimer on the Labels of Formula Milk Products Intended for Infants and Young Children Aged 1 to 36 Months

Ijaz Mustafa General, Notifications November 5, 2026November 5, 2026
Directive Regarding Mandatory Printing of Disclaimer on The Labels of Formula Milk Productis Intended For Infants and Young Children Aged 1 to 36 MonthsDownload

S.R.O. 1915(I)/2026, Notification of Amendments in the Drugs (Research) Rules 1978 (28.10.2026)

Ijaz Mustafa General, Notifications, SROs October 29, 2026October 29, 2026
Notification of Amendments in the Drugs (Research) Rules 1978 (28.10.2026)Download

Development of Medical Devices Module on PSW

Ijaz Mustafa General, Medical Devices, Notifications October 17, 2026October 17, 2026
Medical devices import clearanceDownload

Compliance of 2D Barcoding and Serialization (Track & Trace System) for all Manufactured and Imported Pharmaceutical Products w.e.f. 9th October, 2026

Ijaz Mustafa General, Notifications October 8, 2026October 8, 2026
doc_20261008125350286Download

S.R.O. 1660(I)/2026 (Revised DRAP Regulatory Fee for Therapeutic Goods)

Ijaz Mustafa General, Notifications, SROs October 1, 2026October 1, 2026
Revised DRAP Regulatory Fee for Therapeutic Goods (29.09.2026)Download
  • ← Previous
  • DRAP at a Glance
    • What We Do?
    • Vision & Mission
    • CEO’s Message
  • Organization
    • Organizational Structure
    • Divisions
    • Policy Board
    • Members of Authority
    • Information and Transparency
    • Strategic Plan 2026-2030
  • Legislation
    • Acts
    • Rules
    • Regulations
    • SROs
    • Notifications
  • Boards and Committees
    • Central Licensing Board
    • Registration Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee
    • Committee on Advertisements
  • Quality Management System
    • Quality Policy
    • Management Reviews

Quick Navigation

     
  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem
  • <
  • <